Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Adjuvant chemotheapy
DRUG
2 trials
Sponsors
Duke University
, The First Affiliated Hospital with Nanjing Medical University
Conditions
Non-small Cell Lung Cancer Stage I
Resectable Pancreatic Cancers
Unknown Phase
Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
Completed
NCT02318095
Duke University
Resectable Pancreatic Cancers
Start: 2015-02-17
End: 2022-11-14
Updated: 2023-10-26
Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC
Completed
NCT07250360
The First Affiliated Hospital with Nanjing Medical University
Non-small Cell Lung Cancer Stage I
Start: 2015-01-01
End: 2025-06-01
Updated: 2025-11-26
Related Papers
A phase II trial of neoadjuvant gemcitabine/nab-paclitaxel and SBRT for potentially resectable pancreas cancer: An evaluation of acute toxicity.
Journal of Clinical Oncology
2018-05-20
4 citations